Mindset Pharma Announces Exercise of Over-Allotment Option for Additional Gross Proceeds of $1.052 Million
Toronto, Ontario–(Newsfile Corp. – April 19, 2021) – Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company“) is pleased to announce that in connection with its previously announced “bought deal” public offering (the “Offering“) underwritten by Canaccord Genuity Corp. (the “Lead Underwriter“), as lead underwriter and sole bookrunner, along with Stifel […]
